Stem Cell Debate and the Courts
Francis Collins,the NIH and the Federal District Court for the District of Colombia (Judge Royce C. Lamberth). Francis Collins, evangelicals, and stem cells : The New Yorker Court Ends Ban on U.S. Stem Cell Financing, for Now – NYTimes.com Court of Appeal Stay Drives Stem Cell Stocks |...
ZymoGenetics (ZGEN) Buyout Boosts Biotech Stocks
Zymogenetics (ZGEN) stock soared 84% today on the $9.75 ($885M)buyout offer from Bristol-Myers Squibb (BMY). Bristol was also up 1% even though the acquisition is dilutive to 2011 earnings. Bristol was seeking the the ZGEN Hepatitis C drug PEG-Interferon lamda which is in Phase 2 studies and...
Biotech Rides the September 1 Rally with a 2.5% Move Up
Biotech stocks perked up today emboldened by a new month and ISM data including some positive growth from China’s manufacturing sector. Apple headlines with the iPOD and Apple TV helped catalyze the NASDAQ move. Biotech went along for the ride with most ETF’s up 2%+ and our Mid-Cap...
Good Riddance to August 2010-Part 2 Safe Havens in Biotech and Gold
See Part One of the August review regarding the “bondfest”. We’ll spare you the review of what happened in August but now you know what worked- bonds and gold. Gold ended the month up 5.61% as it survived a correction under 1200 and brought in investors as fears of double dip...
Good Riddance to August 2010- Part 1 Bonds for Everyman
The gloom and doomers are still out in force today but facing a little headwind as the market is stable to up helped by home prices and consumer confidence. Apparently the bulls were on vacation this August or frozen from clicking on something to buy except bonds. However the bond bulls rule...
